Other Names for this Disease
- Malignant nodular/clear cell hidradenoma
- Malignant acrospiroma
- Malignant clear cell acrospiroma
- Clear cell eccrine carcinoma
- Primary mucoepidermoid cutaneous carcinoma
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
Because hidradenocarcinoma is quite rare, there are no established guidelines for treatment. Treatment is determined by the size and location of each particular cancer and the extent to which cancer cells may have spread to nearby lymph nodes or tissues. Surgery is often the first step and aims to remove as much of the cancer as possible. Both a traditional surgical technique, known as wide local excision, and the newer Mohs micrographic surgery have been used to remove hidradenocarcinomas. Radiation therapy, performed by a doctor known as radiation oncologist, has been used after surgery in patients with hidradenocarcinoma to destroy any cancer cells that may remain at the original location of the tumor or in the lymph nodes. Chemotherapy, performed by a doctor known as a medical oncologist, has not yet been proven as effective treatment for hidradenocarcinomas.
Last updated: 11/17/2011
- Gauerke S, Driscoll JJ. Hidradenocarcinoma: A Brief Review and Future Directions. Archives of Pathology & Laboratory Medicine. May 2010; 134:781-785. http://www.ncbi.nlm.nih.gov/pubmed/20441512. Accessed 11/17/2011.
- Yavel R, Hinshaw M, Rao V, Hartig GK, Harari PM, Stewart D, Snow SN. Hidradenomas and a hidradenocarcinoma of the scalp managed using Mohs micrographic surgery and a multidisciplinary approach: case reports and review of the literature. Dermatologic Surgery. 2009; 35:273-281. http://www.ncbi.nlm.nih.gov/pubmed/19215270. Accessed 11/16/2011.
- Wong A, Mollick DK, Siegel, DM. Eccrine Carcinoma. eMedicine. March 26, 2010; http://emedicine.medscape.com/article/1101796-overview. Accessed 10/25/2010.